Vectorious Medical Technologies developed the V-LAP, the world's first in-heart microcomputer - enabling optimal treatment for heart disease patients, increasing their quality of life and life expectancy.
The V-LAP sensory implant is the first digital, wireless, battery-less device that can communicate from deep within the body. It monitors the heart’s left atrium pressure (LAP) which has been proven to be the earliest, most accurate and effective predictor for heart failure deterioration. Vectorious' V-LAP received the FDA's Breakthrough Device Designation for heart failure.
Vectorious is actively conducting clinical studies in Europe (Italy, Germany, UK and Israel) for the purpose of obtaining a CE mark. It is expected to launch a clinical study in the US in 2022.
Location: Israel, Tel Aviv District, Tel Aviv-Yafo
Member count: 11-50
Total raised: $2M
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | RAD Biomed | radbiomed.... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 16.07.2018 | Series B | $2M | - | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 07.03.2018 | This Israeli startup has developed the world’s first miniatu... | Israeli medical technology startup, Vectorious Medical Technologies, has developed the world’s first... | techstartu... |
| 26.02.2015 | Vectorious Medical Technologies Closes $5M Financing | Vectorious Medical Technologies, a Tel Aviv, Israel-based medical device company, closed a $5m finan... | finsmes.co... |